The TPP will make all this even worse. If ratified in this country, as it could be in a lame duck Congress after the November elections, the TPP would drive drug prices in the U. S. even higher than they now are, limit competition further, and prevent the government from negotiating drug prices, as the Veterans Administration has done for many years, successfully gaining discounts of about 42 percent.
This is in effect a last ditch holdup of the federal government as the industry faces a future of less profitability unless it once again gets its way for further subsidization.
NHI would bring us public financing tied to a private delivery system, not a government takeover as conservatives claim
The rising burden of health care costs is unsustainable for patients, families, and taxpayers. We will have to deal with it sooner than later. When that time comes, we will have to take a societal perspective in deciding, based on scientific evidence, what services can be provided for all Americans, not just the most affluent among us.
Although many technological advances have been of great benefit to individual patients and society, such as replacement of hips and knees, coronary bypass surgery, and cataract surgery with prescription intra-ocular lens replacement, there are downsides to the rapid adoption of new technologies as well.
Despite some 30 years’ failed expectations that more cost-sharing by patients will contain costs of health care, why do we continue with this policy that increasingly makes health care inaccessible and unaffordable to a growing part of our population?
The “system” under the ACA is collapsing as many insurers exit markets that are not sufficiently profitable, as the costs of insurance and health care continue to escalate, and as the ranks of the underinsured grow. We have to recognize that multi-payer, profit-oriented health care financing is not sustainable for either patients, their families, or taxpayers.
Government is instituted for the common good; for the protection, safety, prosperity and happiness of the people; and not for the profit, honor, or private interest of any one man, family or class of men. – John Adams, second president of the United States
2017 could well be the year for H.R. 676, the Expanded and Improved Medicare for All bill in the House. Now is a moment calling for political courage and will.
We should ask why we still don’t have an ongoing, evidence-based mechanism to evaluate the comparative clinical and cost effectiveness of health services. The answer is that it has been opposed successfully to date by the economic and political power of the vested interests that profit from the status quo of our deregulated marketplace.
Physicians for a National Health Program's blog serves to facilitate communication among physicians and the public. The views presented on this blog are those of the individual authors and do not necessarily represent the views of PNHP.
PNHP Chapters and Activists are invited to post news of their recent speaking engagements, events, Congressional visits and other activities on PNHP’s blog in the “News from Activists” section.